BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18503586)

  • 1. The labile iron pool in human erythroid cells.
    Prus E; Fibach E
    Br J Haematol; 2008 Jun; 142(2):301-7. PubMed ID: 18503586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of iron chelators on labile iron and oxidative status of thalassaemic erythroid cells.
    Prus E; Fibach E
    Acta Haematol; 2010; 123(1):14-20. PubMed ID: 19923794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometry measurement of the labile iron pool in human hematopoietic cells.
    Prus E; Fibach E
    Cytometry A; 2008 Jan; 73(1):22-7. PubMed ID: 18044720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo evidence for the functional heterogeneity of transferrin-bound iron. IV. Selective uptake by erythroid precursors of radioiron from portal vein plasma transferrin during intestinal iron absorption.
    Okada S; Chipman B; Brown EB
    J Lab Clin Med; 1977 Jan; 89(1):51-64. PubMed ID: 830782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vitro study on thalassemic erythroid precursors in liquid culture.
    Khuhapinant A; Bunyaratvej A; Sahaphong S; Pattanapanyasat K; Fucharoen S
    Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 3():82-92. PubMed ID: 9640605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of membrane alpha4beta1, alpha5beta1 integrins and transferrin receptor on erythroblasts in splenectomized patients with beta-thalassemia intermedia. Parallel assessment of serum soluble transferrin receptors levels.
    Kossiva L; Paterakis G; Tassiopoulos S; Papadhimitriou SI; Voukouti E; Gligori I; Rombos Y
    Ann Hematol; 2003 Sep; 82(9):579-84. PubMed ID: 12904899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative treatment paradigm for thalassemia using iron chelators.
    Szuber N; Buss JL; Soe-Lin S; Felfly H; Trudel M; Ponka P
    Exp Hematol; 2008 Jul; 36(7):773-85. PubMed ID: 18456387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transferrin receptors and iron uptake during erythroid cell development.
    Iacopetta BJ; Morgan EH; Yeoh GC
    Biochim Biophys Acta; 1982 May; 687(2):204-10. PubMed ID: 6284220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Labile iron pool as a parameter to monitor iron overload and oxidative stress status in β-thalassemic erythrocytes.
    Chutvanichkul B; Vattanaviboon P; Mas-Oodi S; U-Pratya Y; Wanachiwanawin W
    Cytometry B Clin Cytom; 2018 Jul; 94(4):631-636. PubMed ID: 29486524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transferrin endocytosis and iron uptake during erythroid cell development.
    Iacopetta BJ; Morgan EH
    Biomed Biochim Acta; 1983; 42(11-12):S182-6. PubMed ID: 6675690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous iron increases hemoglobin in beta-thalassemic mice.
    Ginzburg YZ; Rybicki AC; Suzuka SM; Hall CB; Breuer W; Cabantchik ZI; Bouhassira EE; Fabry ME; Nagel RL
    Exp Hematol; 2009 Feb; 37(2):172-83. PubMed ID: 19059700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of normal erythropoiesis by flow cytometry: important considerations for specimen preparation.
    Wangen JR; Eidenschink Brodersen L; Stolk TT; Wells DA; Loken MR
    Int J Lab Hematol; 2014 Apr; 36(2):184-96. PubMed ID: 24118926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of Tmprss6- ASO and the iron chelator deferiprone improves erythropoiesis and reduces iron overload in a mouse model of beta-thalassemia intermedia.
    Casu C; Aghajan M; Oikonomidou PR; Guo S; Monia BP; Rivella S
    Haematologica; 2016 Jan; 101(1):e8-e11. PubMed ID: 26405152
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective loss of younger erythrocytes from blood circulation and changes in erythropoietic patterns in bone marrow and spleen in mouse anemia induced by poly-dispersed single-walled carbon nanotubes.
    Bhardwaj N; Saxena RK
    Nanotoxicology; 2015; 9(8):1032-40. PubMed ID: 25831400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron-chelator complexes as iron sources for early developing human erythroid precursors.
    Leimberg JM; Prus E; Link G; Fibach E; Konijn AM
    Transl Res; 2008 Feb; 151(2):88-96. PubMed ID: 18201676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythroid bone marrow activity and red cell hemoglobinization in iron sufficient beta-thalassemia heterozygotes as reflected by soluble transferrin receptor and reticulocyte hemoglobin in content. Correlation with genotypes and Hb A(2) levels.
    Skarmoutsou C; Papassotiriou I; Traeger-Synodinos J; Stamou H; Ladis V; Metaxotou-Mavrommati A; Stamoulakatou A; Kanavakis E
    Haematologica; 2003 Jun; 88(6):631-6. PubMed ID: 12801838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric analysis of human bone marrow perfusion cultures: erythroid development and relationship with burst-forming units-erythroid.
    Rogers CE; Bradley MS; Palsson BO; Koller MR
    Exp Hematol; 1996 Apr; 24(5):597-604. PubMed ID: 8605964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of piracetam on erythropoiesis and leukopoiesis in rats.
    Nyagolov Y; Dyankov E; Ganchev T
    Acta Physiol Pharmacol Bulg; 1993; 19(4):97-100. PubMed ID: 8203283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of deferasirox and deferiprone on cellular iron load in the human hepatoma cell line HepaRG.
    Gaboriau F; Leray AM; Ropert M; Gouffier L; Cannie I; Troadec MB; Loréal O; Brissot P; Lescoat G
    Biometals; 2010 Apr; 23(2):231-45. PubMed ID: 19997770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemoglobin synthesis in bone marrow of patients with beta O and beta +-thalassaemia.
    Musumeci S; Schilirò G; Romeo MA; Pizzarelli G; Fischer A; Russo G
    Acta Haematol; 1981; 65(3):170-6. PubMed ID: 6785970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.